Keynote, Invited and Guest Speakers for 2024

The BAD Conference & Events Committee is extremely grateful to the contribution of the Keynote, Invited and Guest lecturers that attend the BAD Annual Meeting speaking in the Plenary and concurrent sessions. Some are familiar BAD Members, whilst others are from outside both the association and the specialty. All offer an invaluable educational benefit to our members and we are very thankful.

Details will appear here shortly on the Keynote and Invited Lecturers for the 2024 Annual Meeting.

Tuesday 2nd July – Plenary Speakers

Samantha Vaughan Jones is Consultant Dermatologist at Ashford and St Peter’s Hospital (ASPH) Foundation Trust with a specialist interest in pregnancy-related skin disease. She qualified from St Thomas’s Hospital UMDS then did general medicine at Kingston and Chertsey before completing her specialist training in Dermatology at St John’s Institute. There she spent two years in research in the IMF lab with Professor Martin Black, publishing her MD thesis on immunopathology findings in the pregnancy dermatoses.

She runs a pregnancy skin clinic at Ashford and St Peter’s, accepting referrals from obstetricians, community midwives and local GPs, along with tertiary referrals from other dermatologists.

She’s published articles and book chapters on the pregnancy dermatoses and has lectured and chaired symposia at the AAD, EADV, World Congress of Dermatology as well as Obstetric Medicine, Foetal & Maternal medicine courses and conferences.

She chaired the EADV Pregnancy Task Force from 2016-2020 and introduced the EADV Fostering course on pregnancy-related skin diseases for European residents. Within the Pregnancy Task Force she has contributed to the patient information leaflets on skin diseases in pregnancy published on the EADV website.

She was educational supervisor for GP specialty trainees in dermatology and interviewer for undergraduate medical school entry to King’s College, London. Her other interests include dermoscopy and teaching.

Her outside interests include tennis and pilates. She was previously a fitness instructor, completing her Exercise to Music course while working at St John’s when several members of the IMF lab were her guinea pigs.

Dr Sobanko is a distinguished dermatologic surgeon specializing in Mohs micrographic surgery, surgical reconstruction, laser surgery, and cosmetic dermatology. Currently serving as the Associate Professor and Director of Cosmetic Dermatology & Laser Surgery at The University of Pennsylvania, he passionately mentors medical students, residents, and fellows.

With a prolific academic record, Dr Sobanko has authored over 150 scientific articles, 12 textbook chapters, and co-authored the acclaimed “Safety in Office-Based Dermatologic Surgery.” His ground breaking research, supported through grants from the Dermatology Foundation and the American Society for Dermatologic Surgery, delves into the profound impact of physical appearance on patients’ lives.

Dr Sobanko’s diverse research interests span information asymmetry in healthcare, melanoma management, cost-effective care, and minimally invasive cosmetic procedures. Committed to global health, he extends his surgical expertise to skin cancer patients worldwide, undertaking missions in Brazil, South Africa, India, and Vietnam.

Recognized as a thought leader in dermatology, Dr Sobanko is frequently cited by prominent media outlets, including Time Magazine, Reuters, NBC Today Show, and the Los Angeles Times. His consistent excellence has earned him the title of “Top Doctor” by Philadelphia Magazine annually from 2018-2023.

In 2017, he received the prestigious “Provider of the Year” award from the Clinical Practice at the University of Pennsylvania, and in 2023, he was honoured with induction into the Academy of Master Clinicians, the highest clinic honour at Penn Medicine.

Adding to his repertoire, Dr. Sobanko recently completed the Executive MBA Program at the Wharton School of Business, augmenting his capabilities to further contribute to his clinical, research, and global health missions.

Prof Jemima Mellerio trained in dermatology in South London at St John’s Institute of Dermatology and King’s College Hospital. Undertaking her MD at St John’s Institute on Genotype-Phenotype Correlations in Epidermolysis Bullosa (EB) sparked an interest in genetic skin fragility disorders that has endured.  She has been a consultant dermatologist since 2003 and is based at St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospital, London she leads the Adult Epidermolysis Bullosa (EB) Service.  She has been an Honorary Professor of Paediatric Dermatology at King’s College London since 2016.  Previously, she was also the dermatologist to the Paediatric EB Service at Great Ormond Street Hospital for 15 years. Jemima’s clinical interests are EB and Mendelian genodermatoses, particularly ichthyoses and other disorders of keratinisation, as well as paediatric dermatology.

Wednesday 3rd July – Plenary Speakers

Susan Taylor, M.D.

Dr. Misha Rosenbach is the Paul R. Gross Professor of Dermatology and Internal Medicine (Rheumatology) at the Perelman School of Medicine at the University of Pennsylvania.  He is the co-director of the inpatient consult service, and serves a variety of educational roles including Vice Chair of Education and program director of the dermatology residency.  Dr. Rosenbach’s clinical practice is focused on complex medical dermatology, where he runs a sarcoidosis clinic, with his research focused primarily on sarcoidosis, granulomatous skin conditions, and neutrophilic dermatoses.  He has published more than 250 peer reviewed articles, multiple chapters, and 6 textbooks, including serving as one of the editors of Andrew’s Diseases of the Skin.  Dr. Rosenbach is involved in Dermatology nationally as well, and is the former deputy editor of JAMA Dermatology and remains on its editorial board. He is the immediate past president of the Medical Dermatology Society, and has leadership roles in the Society of Dermatology Hospitalists and in the American Academy of Dermatology, particularly in the area of Climate Change & Sustainability.

Martin Metz, M.D. is Professor of Dermatology at the Institute of Allergology at the Charité – Universitätsmedizin Berlin, Germany and Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology. He received his medical education at the Free University of Berlin and the Humboldt University of Berlin. He was trained in dermatology at the King’s College Hospital, London and at the University of Mainz, and in experimental pathology at Beth Israel Deaconess Medical Centre and Harvard Medical School in Boston (1997–98) and at Stanford University (2004–06) in the USA. He is board certified in Dermatology and Allergology, head of the specialty outpatient clinics for pruritus, head of translational research and deputy head of clinical research at the Institute of Allergology, Charité – Universitätsmedizin Berlin. His main scientific areas of interest are mast cell biology, neuroimmunology, inflammation and innate immunity, the major clinical and translational focus is on pruritus and mast cell mediated diseases.

Dr. Ho is a Consultant Dermatologist and Lecturer at The University of the West Indies (UWI), Mona Campus. He received his MBBS from UWI Mona, and completed his Dermatology training in the International Graduate Program at Boston University School of Medicine. He is additionally fellowship-trained and board-certified in Dermatopathology. Dr. Ho is the Co-Director of the Dermatology residency program at the UWI, serves as the current president of the Dermatology Association of Jamaica and is Deputy Editor-in-Chief for PathologyOutlines, Dermatopathology Section. His clinical interests include complex medical dermatology, autoimmune connective tissue disease and in-patient dermatology

Thursday 4th July – Plenary Speakers

Dr David de Berker – Arthur Rook Oration

Associate Professor Liam Caffery is a health informatics research fellow at the University of Queensland in Brisbane, Australia. He has a particular interest in dermatology informatics. He is the technology lead for the Australian Centre of Excellence in Melanoma Imaging and Diagnosis. He developed the telehealth practice guidelines and the position statement for the use of AI in dermatology for the Australasian College of Dermatologists. He holds several national and international leadership positions including Vice President of the Australian Telehealth Society, Chair of the Dermatology Working Group for the DICOM (Digital Imaging and Communication in Medicine, the  international standards development organisation for medical imaging), Tele-imaging task force lead for the International Dermoscopy Society, Board of Directors for the International Digital Health in Dermatology Society, and working group lead for the International Skin Imaging Collaborative.

Tuesday 2nd July – Special Interest Group Speakers

Wednesday 3rd July – Special Interest Group Speakers

Prof Siddharth Banka

Sid is a Clinician Scientist who combines genomics with clinical and functional studies to improve diagnosis, management and treatment of rare human genetic disorders.

Sid graduated in Medicine (MBBS) from Lokmanya Tilak Medical College (University of Mumbai) in 2002, obtained Membership of Royal College of Paediatrics and Child Health (MRCPCH) in 2006 and joined Clinical Genetics training programme in Manchester in 2007. He was an NIHR Research Training Fellows from 2008 to 2011 and was awarded PhD by the University of Manchester in 2012. He was appointed as Clinical Senior Lecturer and Consultant Clinical Geneticist in 2013 and made a full professor in 2021.

Currently, Sid is a Professor of Genomic Medicine and Rare Diseases at the University of Manchester, a Consultant Clinical Geneticist at the Manchester Centre for Genomic Medicine, Founding Clinical Director of the Manchester Rare Conditions Centre, Co-lead of the Rare Conditions theme of the NIHR Manchester Biomedical Research Centre, Co-Director of the EpiGenRare node of the MRC UK Rare Disease Research Platform, and Co-lead for the NHSE Rare Disease Genomics Network of Excellence.

His current research programs focus on novel disease and disease-gene discovery​; improving diagnosis of undiagnosed patients through innovative data analysis and multi-omic approaches​; understanding mechanisms of neurodevelopmental diseases, including chromatin disorders and inborn errors of metabolism; and natural history studies and therapeutic clinical trials in developmental diseases.

Speaker TBC

Professor David J Gawkrodger

David Gawkrodger is honorary professor in dermatology at the University of Sheffield. He has researched extensive in contact dermatitis and vitiligo. Over the past few years he has developed an interest in the history of medicine, most recently the health of British armies in the 19th to the 20th century.”

Thursday 4th July – Special Interest Group Speakers

Follow B.A.D on Twitter